AGP Picks
View all

European Global Times
Provided by AGP

European Global Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on August 20, 2026

Le WSOP Super Circuit arrive au Canada : plus de 14 M$ en bourses garanties à Montréal
Aug. 20, 2026

Le WSOP Super Circuit arrive au Canada : plus de 14 M$ en bourses garanties à Montréal

Indeterminate GlobeNewswire
Transaction in Own Shares
Aug. 20, 2026

Transaction in Own Shares

Indeterminate GlobeNewswire
Shufti Launches Flagship Podcast Series Called ‘Built By Shufti’ Showcasing a Decade of Custom Innovation for 2,000+ Businesses
Aug. 20, 2026

Shufti Launches Flagship Podcast Series Called ‘Built By Shufti’ Showcasing a Decade of Custom Innovation for 2,000+ Businesses

Indeterminate GlobeNewswire
Crypto News: New Presale Moonberg Hits $300k As Monero Price Prediction Targets $2,000
Aug. 20, 2026

Crypto News: New Presale Moonberg Hits $300k As Monero Price Prediction Targets $2,000

Indeterminate GlobeNewswire
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement
Aug. 20, 2026

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

Indeterminate GlobeNewswire
BioNTech präsentiert auf der WCLC 2026 Fortschritte ihrer spätklinischen Pipeline bei Lungenkrebs und erste globale Daten zur innovativen Behandlungskombination aus Pumitamig und Elfetabart Drozuntecan
Aug. 20, 2026

BioNTech präsentiert auf der WCLC 2026 Fortschritte ihrer spätklinischen Pipeline bei Lungenkrebs und erste globale Daten zur innovativen Behandlungskombination aus Pumitamig und Elfetabart Drozuntecan

Indeterminate GlobeNewswire
BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026
Aug. 20, 2026

BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026

Indeterminate GlobeNewswire
ExGen Announces TSXV Approval of Extension and Upsize of Private Placement and Provides Corporate Update
Aug. 20, 2026

ExGen Announces TSXV Approval of Extension and Upsize of Private Placement and Provides Corporate Update

Indeterminate GlobeNewswire
Scottish Water Becomes First Utility in the World to Use Innovative New Technology to Reduce Laboratory Plastic Waste 
Aug. 20, 2026

Scottish Water Becomes First Utility in the World to Use Innovative New Technology to Reduce Laboratory Plastic Waste 

Indeterminate GlobeNewswire
Arla Foods Ingredients mengurangi emisi gas melalui investasi yang signifikan di Videbæk
Aug. 20, 2026

Arla Foods Ingredients mengurangi emisi gas melalui investasi yang signifikan di Videbæk

Indeterminate GlobeNewswire
Arla Foods Ingredients mengurangkan pelepasan gas melalui pelaburan besar di Videbæk
Aug. 20, 2026

Arla Foods Ingredients mengurangkan pelepasan gas melalui pelaburan besar di Videbæk

Indeterminate GlobeNewswire
Arla Foods Ingredients ลดการปล่อยก๊าซด้วยการลงทุนครั้งสำคัญในวีเดแบก
Aug. 20, 2026

Arla Foods Ingredients ลดการปล่อยก๊าซด้วยการลงทุนครั้งสำคัญในวีเดแบก

Indeterminate GlobeNewswire
Arla Foods Ingredients giảm phát thải khí nhà kính nhờ khoản đầu tư lớn tại Videbæk
Aug. 20, 2026

Arla Foods Ingredients giảm phát thải khí nhà kính nhờ khoản đầu tư lớn tại Videbæk

Indeterminate GlobeNewswire
Half-Year Results 2026: Boskalis delivers solid performance amid challenging market conditions
Aug. 20, 2026

Half-Year Results 2026: Boskalis delivers solid performance amid challenging market conditions

Indeterminate GlobeNewswire
Halfjaarcijfers Boskalis 2026: Solide prestatie ondanks uitdagende marktomstandigheden
Aug. 20, 2026

Halfjaarcijfers Boskalis 2026: Solide prestatie ondanks uitdagende marktomstandigheden

Indeterminate GlobeNewswire
Equinor ASA: Announcement of cash dividend of NOK 3.6882 per share for first quarter 2026
Aug. 20, 2026

Equinor ASA: Announcement of cash dividend of NOK 3.6882 per share for first quarter 2026

Indeterminate GlobeNewswire
Equinor ASA: Annonsering av kontantutbytte på NOK 3,6882 per aksje for første kvartal 2026
Aug. 20, 2026

Equinor ASA: Annonsering av kontantutbytte på NOK 3,6882 per aksje for første kvartal 2026

Indeterminate GlobeNewswire
Aegon announces Chief Financial Officer transition
Aug. 20, 2026

Aegon announces Chief Financial Officer transition

Indeterminate GlobeNewswire
Aegon reports first half year 2026 results
Aug. 20, 2026

Aegon reports first half year 2026 results

Indeterminate GlobeNewswire
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement
Aug. 20, 2026

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

European Global Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.